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PROPOSITIONS 
accompanying the thesis 
Prediction of "BRCAness" in breast cancer by array comparative genomic hybridization 
by Simon A. Joosse 
 
1. Array CGH is a powerful technique to study a tumor's genetic makeup and divide 
breast cancer patients into clinically relevant subgroups (this thesis) 
2. BRCA1 deficiency leads to a typical pattern of chromosomal aberrations in 
hereditary and sporadic breast cancer (this thesis) 
3. Aneuploidy of chromosomes and chromosomal subregions can be effectively used to 
predict "BRCAness" in hereditary and sporadic breast cancer in the clinic (this thesis) 
4. Although signature chromosomal aberrations can assign tumors to a subgroup, each 
tumor remains a unique entity (this thesis) 
5. All triple-negative breast tumors should be tested for BRCA1 deficiency (this thesis) 
6. To metastasize, tumor cells undergo epithelial-to-mesenchymal transition to enter 
the bloodstream (Ledford. Nature 2011; 472:273) 
7. Genomic instability is an active process that drives tumor evolution (Navin, et al.  
Genome Res 2010; 20:68-80) 
8. Tumor initiation as a result of BRCA1 deficiency can only occur before stem cell 
differentiation (Lim, et al. Nat Med 2009; 15:907-13) 
9. Clinical management will be solely directed by the tumor's genetic makeup in the 
near future (Majewski & Bernards. Nat Med 2011; 17:304-12) 
10. Our current high-throughput, whole-genome experiments drown us in information, 
but without proper bioinformatics we are still starving for knowledge 
11. Facts are stubborn things, but statistics are more pliable (Mark Twain) 
